Sector Data

• Known as the birthplace of biotechnology, the San Francisco Bay Area lays claim to the largest concentration of biotech companies in the nation.
• In total, the Bay Area is home to nearly 1,377 companies, with 75 companies in San Francisco.
• In the most recent published statistics on U.S. bioscience clusters, bioscience companies based in the Bay Area reported total worldwide revenues of $4.1 billion, exports of $2.7 billion and NIH grant awards of $1.2 billion, with over $500 million going specifically to San Francisco companies.
• The Bay Area’s 1,377 Life Sciences and Biotechnology companies employ more than 140,000 people. Direct and indirect employment together amounts to 250,000 employees. The Bay Area employs more than the half of the Biomedical industry workforce in California.
• In the second quarter of 2011, biotechnology was the leading sector in the U.S. to receive the most investment totaling nearly $1.24 billion. Northern California venture capital firms invested $159 million in 17 deals, representing 12.84% of total dollars invested in biotechnology.
• California is the leading state in venture capital funding in Bioscience with $2175 billion in 2010, long way ahead Massachusetts ($928) and Washington states ($216). 
• The largest aggregation of research universities and federal research institutions in the U.S. is in the Bay Area. In 2010, San Francisco companies and universities reported 144 NIH grants awards of more than $100 million.
• The Bay Area universities produce more Ph.D. scientists & engineers than any other area in U.S.
• UCSF has created the Mission Bay campus a Bioentrepreneurship Center. It offers mentoring and training for faculty members whose discoveries might form the basis of a spin-off, as well as funding for translational drug development. The center is supported by the QB3 Institute.

• The California Institute for Regenerative Medicine (CIRM) is a $3 billion funding initiative for stem cell research. The CIRM has awarded $271 millions through grants, loans and matching funds since the program's inception in 2005, including 4 universities located in the Bay Area:

Stanford University: 63 grants totaling $192,520,199  

 UC San Francisco: 38 grants totaling $114,819,892

UC Berkeley: 16 grants totaling $42,398,089   

UC Santa Cruz: 9 grants totaling $19,468,564   

• Institute for Quantitative Biomedical Research (QB3) is a collaborative of UC San Francisco, UC Berkeley and UC Santa Cruz. The institute has an impressive list of 222 scientists housed at Mission Bay in San Francisco. QB3 is part of a public/private biomedical research park focusing on fundamental discoveries, new product development and biomedical training for the next generation of biotech workers.
• Gladstone Institute—adjacent to the UC San Francisco (UCSF) Mission Bay Campus—is a six-story, 180,000-square-foot lab research facility developed by the J. David Gladstone Institutes, a non-profit bioresearch facility closely affiliated with UCSF, which carries out research in virology, immunology, neurological disease and cardiovascular disease. The building was occupied in late 2004 and includes research and administrative space.
• In June 2007, an anonymous donor pledged $150 million to the UCSF Comprehensive Cancer Center. This amount is the largest known gift to a U.S. cancer center. Funds will be used to strengthen the Center’s research base in order to transform fundamental discoveries into clinical results. 
• Energy Biosciences Institutes—In February 2007 UC Berkeley won the international contest to house the Energy Biosciences Institute. The 10 year, $500 million initiative is funded by BP.

• Mission Bay, the hub of San Francisco’s life sciences industry, spans 303 acres in the heart of the burgeoning and dynamic South of Market area. The neighborhood is home to the California Institute for Regenerative Medicine, The Gladstone Institute, QB3, and UCSF’s 30-acre medical campus and future world-class hospital and family cancer research center. This hub of knowledge and innovation is also home to prominent private sector companies, including: Celgene Corp, Presidio Pharmaceuticals, Inc., FibroGen, Ion Torrent Systems, Inc., Bayer, Pfizer and Nextar.
• Alexandria Real Estate Equities, the preeminent international developer of life science-focused properties, has created 155,000 square feet of move-in ready, turnkey labs/office suites, with an additional 300,000 square feet of spaces coming available in 2011.
• The China Basin Project, immediately adjacent to Mission Bay, has 222,000 square feet of flexible space, and premium office space will be available in a new Mission Bay building during the same period.
• More than 80 percent new and under construction life-science inventory in the Bay Area is located in San Francisco and San Mateo counties with already more than 35 percent of life science real estate located in the city of South San Francisco alone.
• The Clark Center awarded in 2000 to Stanford university Bio-X program won the R&D magazine’s prestigious “Lab of the year” award in 2004. This center provides highly innovative facilities and organization, large interaction within the campus and very flexible and reconfiguring office space.
• Other areas of the City offer attractive opportunities as well, including the nearby Financial District and South of Market area.

Additional data are available online at:

http://www.baybio.org/ 

The BayBio Institute focuses on supporting innovation, entrepreneurship, workforce development and education for the Northern California life science industry through purchasing programs, events and advocacy.

https://www.pwcmoneytree.com/

The MoneyTree Report is a study about Venture Capital Investment in the United States carried out collaborately by PricewaterhouseCoopers and the National Venture Capital Association based upon data from Thomson Reuters. They provide very current regional numbers about capital investment in key industries.

http://www.chi.org/industry/index.aspx

• QuickFacts
• Key Business Sectors
• Getting Started
• Incentives
• Commercial Real Estate